REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Beijing Northland Biotech Co.,Ltd. (北京诺思兰德生物技术股份有限公司) (China)

Main Activities: Pharmaceutical and Medicine Manufacturing | Pharmaceutical Preparation Manufacturing
Full name: Beijing Northland Biotech Co.,Ltd. Profile Updated: November 15, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

Beijing Northland Biotechnology Co., Ltd. is mainly engaged in the research and development, production and sales of genetically engineered protein drugs, gene therapy drugs and ophthalmic drugs. The company's main products include gene therapy drugs, recombinant protein drugs, and ophthalmic drugs.

Headquarters
Room A406, No. 5, Shangdi Kaituo Road, Haidian District, Beijing
Beijing; Beijing; Postal Code: 100085

Contact Details: Purchase the Beijing Northland Biotech Co.,Ltd. (北京诺思兰德生物技术股份有限公司) report to view the information.

Website: http://www.northland-bio.com

Basic Information
Total Employees:
Purchase the Beijing Northland Biotech Co.,Ltd. (北京诺思兰德生物技术股份有限公司) report to view the information.
Outstanding Shares:
Purchase the Beijing Northland Biotech Co.,Ltd. (北京诺思兰德生物技术股份有限公司) report to view the information.
Financial Auditors:
Purchase the Beijing Northland Biotech Co.,Ltd. (北京诺思兰德生物技术股份有限公司) report to view the information.
Incorporation Date:
June 03, 2004
Key Executives
Purchase this report to view the information.
Chairman of the Supervisory Board
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
General Manager
Purchase this report to view the information.
Deputy General Manager
Ownership Details
Purchase this report to view the information.
13.31%
Purchase this report to view the information.
10.69%
Purchase this report to view the information.
6.44%
Purchase this report to view the information.
5.66%
Purchase this report to view the information.
3.42%
Subsidiaries
Beijing Northland Biopharmaceutical Co., Ltd.
92%
Beijing Hui En Rand Pharmaceutical Co., Ltd.
43.2%
Company Performance
Financial values in the chart are available after Beijing Northland Biotech Co.,Ltd. (北京诺思兰德生物技术股份有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
-3.36%▼
Total operating revenue
-5.67%▼
Operating profit (EBIT)
-15.22%▼
Net Profit (Loss) for the Period
-19.86%▼
Total assets
-5.27%▼
Total equity
-11.63%▼
Operating Profit Margin (ROS)
-10.73%▼
Net Profit Margin
-13.36%▼
Return on Equity (ROE)
-2.77%▼
Quick Ratio
-1.15%▼
Cash Ratio
-0.71%▼

Similar companies

Sinopharm Group Company Limited
 
Shanghai Pharmaceuticals Holding Co.,Ltd
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
 
JD Health International Inc.
Nanjing Pharmaceutical Company Limited
 
Hubei Biocause Pharmaceutical Co.,Ltd.
Beijing Biostar Pharmaceuticals Co. Ltd.
 
Kunming Longjin Pharmaceutical Co., Ltd. (Kunming) (昆明龙津药业股份有限公司 (昆明))
Broncus Holding Corporation (Hong Kong) (Broncus Holding Corporation (香港))
 
Brii Biosciences Limited
Paranovus Entertainment Technology Ltd.
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo